Akorn Inc | Akorn Inc. | wage and hour violation | 2022 | IL-DOL | $7,000 |
ABBVIE US LLC | AbbVie | wage and hour violation | 2021 | IL-DOL | $25,973 |
Amgen Inc. | Amgen | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
Abbott Laboratories | Abbott Laboratories | False Claims Act and related | 2019 | IL-AG | $13,747,929 |
AbbVie Inc. | AbbVie | False Claims Act and related | 2019 | IL-AG | $13,747,929 |
Aventis Pharmaceuticals | Sanofi | False Claims Act and related | 2019 | IL-AG | $14,708,388 |
Forest Laboratories Inc. | AbbVie | False Claims Act and related | 2019 | IL-AG | $7,089,034 |
GlaxoSmithKline LLC | GlaxoSmithKline | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2019 | IL-AG | $49,505,368 |
Novartis Pharmaceuticals | Novartis | False Claims Act and related | 2019 | IL-AG | $21,280,356 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2019 | IL-AG | $41,047,101 |
Pharmacia Corporation | Pfizer | False Claims Act and related | 2019 | IL-AG | $18,960,210 |
Takeda Pharmaceuticals U.S.A. | Takeda Pharmaceutical | False Claims Act and related | 2019 | IL-AG | $5,833,333 |
Abbott Laboratories, Inc. | AbbVie | False Claims Act and related | 2013 | ID-AG | $1,000,000 |
Alpharma USPD, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | ID-AG | $600,000 |
AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Dey, Inc. | Viatris | False Claims Act and related | 2006 | ID-AG | $1,072,700 |
Eli Lilly and Co. | Eli Lilly | off-label or unapproved promotion of medical products | 2009 | ID-AG | $13,000,000 |
Forest Laboratories, Inc. | AbbVie | False Claims Act and related | 2012 | ID-AG | $790,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2011 | ID-AG | $2,000,000 |
Merck Sharp & Dohme Corp. | Merck | False Claims Act and related | 2011 | ID-AG | $1,600,000 |
Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | Viatris | False Claims Act and related | 2012 | ID-AG | $625,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2013 | ID-AG | $750,000 |
Par Pharmaceutical Cos., Inc. | Endo International | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
Pfizer Inc. and Pharmacia Corp. | Pfizer | False Claims Act and related | 2012 | ID-AG | $2,900,000 |
Purepac Pharmaceutical Co. | Pfizer | False Claims Act and related | 2010 | ID-AG | $600,000 |
Sandoz Inc. | Sandoz Group | False Claims Act and related | 2010 | ID-AG | $1,650,000 |
Sanofi-Aventis U.S. LLC | Sanofi | False Claims Act and related | 2012 | ID-AG | $828,500 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | consumer protection violation | 2006 | ID-AG | $198,000 |
Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
Warrick Pharmaceuticals Corp. and Schering-Plough Corp. | Merck | False Claims Act and related | 2011 | ID-AG | $750,000 |
Watson Pharmaceuticals Inc. and Watson Pharma Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2012 | ID-AG | $1,700,000 |
Abbott Laboratories, Inc. | AbbVie | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2009 | IA-AG | $357,000 |
Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
Immunex Corp. | Amgen | False Claims Act and related | 2009 | IA-AG | $357,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | HI-AG | $1,150,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Johnson & Johnson et al. | Johnson & Johnson | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
Merck Sharp & Dohme Corp | Merck | False Claims Act and related | 2010 | HI-AG | $28,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Pfizer, Inc. and Pharmacia Corporation | Pfizer | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
Glenmark Pharmaceuticals, Inc. | Glenmark Pharmaceuticals | HHS civil monetary penalties | 2015 | HHSOIG | $2,887,300 |
Sandoz, Inc. | Sandoz Group | HHS civil monetary penalties | 2015 | HHSOIG | $12,640,000 |
Sandoz, Inc. | Sandoz Group | HHS civil monetary penalties | 2011 | HHSOIG | $230,000 |
Advanced Neuromodulation Systems, Inc. | Abbott Laboratories | HHS civil monetary penalties | 2007 | HHSOIG | $2,950,000 |
Mallinckrodt, Inc. | Mallinckrodt | environmental violation | 2008 | GA-ENV | $5,000 |
Merck & Company, Incorporated | Merck | environmental violation | 2000 | GA-ENV | $40,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2006 | GA-AG | $418,952 |
Cephalon, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2015 | FTC | $1,200,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2009 | FTC | $2,100,000 |
Alpharma, Inc. | Pfizer | price-fixing or anti-competitive practices | 2004 | FTC | $2,500,000 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | FTC | $3,750,000 |
Mylan Laboratories, Inc. | Viatris | consumer protection violation | 2000 | FTC | $100,000,000 |
Mallinckrodt ARD Inc | Mallinckrodt | price-fixing or anti-competitive practices | 2017 | FTC | $100,000,000 |
Indivior, Inc. | Indivior PLC | price-fixing or anti-competitive practices | 2020 | FTC | $10,000,000 |
PHIBRO-TECH, INC. | Phibro Animal Health | railroad safety violation | 2008 | FRA | $5,650 |
Mallinckrodt | Mallinckrodt | railroad safety violation | 2007 | FRA | $10,000 |
Pfizer Inc. | Pfizer | railroad safety violation | 2002 | FRA | $11,250 |
Phibro-Tech Inc. | Phibro Animal Health | railroad safety violation | 2006 | FRA | $6,800 |
Cherokee Pharmaceuticals | Merck | railroad safety violation | 2021 | FRA | $5,000 |
Malincrodt Chemical Company | Mallinckrodt | railroad safety violation | 2022 | FRA | $7,500 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | motor vehicle safety violation | 2006 | FMCSA | $18,560 |
EMD CHEMICALS INCORPORATED | Merck KGaA (EMD) | motor vehicle safety violation | 2006 | FMCSA | $7,614 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | motor vehicle safety violation | 2005 | FMCSA | $15,820 |
EMD CHEMICALS INCORPORATED | Merck KGaA (EMD) | motor vehicle safety violation | 2004 | FMCSA | $13,170 |
Cody Laboratories Inc | Lannett Co. | motor vehicle safety violation | 2018 | FMCSA | $8,510 |
VISTAKON | Johnson & Johnson | environmental violation | 2005 | FL-DEP | $9,771 |
ANDRX PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | environmental violation | 2001 | FL-DEP | $15,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2004 | FL-AG | $807,826 |
General Nutrition Corp. | Harbin Pharmaceutical Group | consumer protection violation | 2002 | FL-AG | $1,000,000 |
Purdue Pharma L.P. | Purdue Pharma | consumer protection violation | 2002 | FL-AG | $2,150,000 |
Roxane Laboratories, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | FL-AG | $278,826,499 |
Allergan Ltd. et al. | AbbVie | off-label or unapproved promotion of medical products | 2022 | FL-AG | $134,200,000 |
Endo Health Solutions and Endo Pharmaceuticals | Endo International | off-label or unapproved promotion of medical products | 2022 | FL-AG | $65,000,000 |
Morton Grove Pharmaceuticals, Inc. | Wockhardt Limited | campaign finance violation | 2007 | FEC | $9,000 |
Astellas Pharma US, Inc. | Astellas Pharma | campaign finance violation | 2022 | FEC | $7,500 |
Advanced Sterilization Products, a division of Ethicon Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2013 | FDA | $1,200,000 |
Genzyme Corporation | Sanofi | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
McNeil-PPC Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2015 | FDA | $25,000,000 |
Endo Health Solutions Inc. | Endo International | off-label or unapproved promotion of medical products | 2014 | FDA | $192,700,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2013 | FDA | $2,200,000,000 |
Wyeth Pharmaceuticals Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
Par Pharmaceutical Companies Inc. | Endo International | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2012 | FDA | $55,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
Abbott Laboratories Inc. | AbbVie | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
Merck, Sharp & Dohme | Merck | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2011 | FDA | $14,500,000 |
Scios Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2011 | FDA | $85,000,000 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | FDA | $25,000,000 |